Veeva Systems Inc
NYSE:VEEV
Net Margin
Veeva Systems Inc
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| US |
|
Veeva Systems Inc
NYSE:VEEV
|
45.6B USD |
27%
|
|
| US |
C
|
Cerner Corp
LSE:0R00
|
31.3B USD |
10%
|
|
| AU |
|
Pro Medicus Ltd
ASX:PME
|
28.5B AUD |
52%
|
|
| US |
|
Doximity Inc
NYSE:DOCS
|
10.9B USD |
39%
|
|
| JP |
|
M3 Inc
TSE:2413
|
1.4T JPY |
14%
|
|
| US |
W
|
Waystar Holding Corp
NASDAQ:WAY
|
6.5B USD |
3%
|
|
| SE |
|
Sectra AB
STO:SECT B
|
60.5B SEK |
27%
|
|
| US |
|
Inspire Medical Systems Inc
NYSE:INSP
|
3.9B USD |
8%
|
|
| IN |
I
|
Inventurus Knowledge Solutions Ltd
NSE:IKS
|
268.3B INR | N/A | |
| US |
V
|
Vocera Communications Inc
F:V00
|
2.4B EUR |
-4%
|
|
| CN |
|
Winning Health Technology Group Co Ltd
SZSE:300253
|
19.5B CNY |
3%
|
Veeva Systems Inc
Glance View
Veeva Systems Inc., born in the heart of Silicon Valley in 2007, embarked on its journey with a clear mission: to revolutionize the pharmaceutical and life sciences industries with cloud-based solutions. Founded by Peter Gassner, who previously held leadership roles at Salesforce and PeopleSoft, Veeva identified a niche opportunity amid the highly-regulated, complex landscape of healthcare. The company began by offering Customer Relationship Management (CRM) software tailored for the life sciences sector, allowing clients to stay compliant with industry regulations while efficiently managing relationships across the intricate healthcare network. Veeva’s CRM solutions gradually became instrumental for pharmaceutical and biotech companies in conducting their marketing, sales, and collaboration activities. As Veeva expanded, it diversified its portfolio by delving into other digital solutions, such as data management and analytics, content management, and regulatory and compliance software. Its Vault platform stood out, providing a unified suite for managing a vast array of business processes and content across powerful cloud applications. This approach enabled Veeva to serve its clientele throughout the drug development lifecycle, from research and development to commercialization. By adopting a subscription-based pricing model, Veeva ensured a steady revenue stream while continuously enhancing its offerings, solidifying its position as both a trusted partner and a critical component of its clients’ operational infrastructure. Through these strategic expansions, Veeva Systems Inc. not only adapted to the evolving demands of the healthcare sector but also reinforced its dominance in the specialized domain of life sciences cloud technology.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Veeva Systems Inc's most recent financial statements, the company has Net Margin of 27.3%.
You don't have any saved screeners yet